期刊
ONCOLOGIST
卷 13, 期 11, 页码 1181-1192出版社
WILEY
DOI: 10.1634/theoncologist.2008-0104
关键词
Childhood cancer survivors; Late effects; Evaluation for late effects; Long-term follow-up guidelines
类别
资金
- [5 U10 CA13539-26S2]
- NATIONAL CANCER INSTITUTE [U10CA013539] Funding Source: NIH RePORTER
The last four decades have seen tremendous improvements in the survival of children diagnosed with cancer, with 5-year survival rates now at 80%. The burgeoning population of childhood cancer survivors creates an obligation to understand the health and well-being of these individuals. The use of cancer therapy at an early age can produce complications that may not become apparent until years later; it has been demonstrated quite conclusively that approximately two thirds of these survivors will experience at least one late effect and about one third will experience a late effect that is severe or life threatening. Long-term complications in childhood cancer survivors, such as impairment in growth and development, neurocognitive dysfunction, cardiopulmonary compromise, endocrine dysfunction, renal impairment, gastrointestinal dysfunction, musculoskeletal sequelae, and subsequent malignancies, are not only related to the specific therapy employed, but may also be determined by individual host characteristics. This review describes some of the known late effects described in childhood cancer survivors in order to suggest reasonable starting points for evaluation of specific long-term problems in this unique and growing population. The Oncologist 2008; 13: 1181-1192
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据